Amgen AMGN
NASDAQ AMGN
$439.20 +7.99 (+1.85%)
As of: Aug 21, 2026 · 11:30 AM EDT

Amgen (AMGN) EBT (2009 - 2026)

Amgen (AMGN) posted quarterly EBT of $2.1 billion for Q1 2026, up 5.63% year-over-year from $2.0 billion in Q1 2025, and up 37.65% quarter-over-quarter from $1.5 billion in Q4 2025.

Amgen (AMGN) EBT (2009 - 2026) Analysis & Trends

Amgen's EBT history runs 18 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

  • In Q1 2026, EBT rose 5.63% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $9.1 billion (up 36.65% YoY), while the FY2025 annual figure was $9.0 billion, up 94.75% from the prior year.
  • EBT for Q1 2026 stood at $2.1 billion, up from $1.5 billion in the prior quarter.
  • The five-year high for EBT was $3.9 billion in Q3 2025, with the low at -$68.0 million in Q1 2024.
  • The 5-year median for EBT is $1.7 billion (2022), against an average of $1.8 billion.
  • The sharpest annual moves came in 2024 and 2025: EBT plunged 101.98% in 2024, then jumped 3001.47% in 2025.
  • Amgen's EBT stood at $1.7 billion in 2022, then tumbled by 51.26% to $852.0 million in 2023, then decreased by 8.22% to $782.0 million in 2024, then surged by 93.61% to $1.5 billion in 2025, then surged by 37.65% to $2.1 billion in 2026.
  • Business Quant data shows AMGN's EBT at $2.1 billion in Q1 2026, $1.5 billion in Q4 2025, and $3.9 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 653.36 Bn 632.60 Bn 17.26 Bn 6.75 Bn
2 AbbVie 470.47 Bn 463.90 Bn 12.70 Bn 4.28 Bn
3 Merck 379.81 Bn 372.67 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 303.09 Bn 295.40 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 258.57 Bn 253.67 Bn 12.86 Bn 2.80 Bn
6 Amgen 237.19 Bn 223.20 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 182.88 Bn 179.70 Bn 6.22 Bn -10.25 Bn
8 Pfizer 161.00 Bn 149.30 Bn 10.94 Bn -653.00 Mn
9 Gsk 105.89 Bn 101.73 Bn 8.24 Bn 474.95 Mn
10 Sanofi 55.24 Bn 47.86 Bn 10.79 Bn 17.19 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.77 Bn
Mar 31, 2026 2.08 Bn
Dec 31, 2025 1.51 Bn
Sep 30, 2025 3.92 Bn
Jun 30, 2025 1.57 Bn
Mar 31, 2025 1.97 Bn
Dec 31, 2024 782.00 Mn
Sep 30, 2024 3.10 Bn
Jun 30, 2024 794.00 Mn
Mar 31, 2024 -68.00 Mn
Dec 31, 2023 852.00 Mn
Sep 30, 2023 1.95 Bn
Jun 30, 2023 1.61 Bn
Mar 31, 2023 3.44 Bn
Dec 31, 2022 1.75 Bn
Sep 30, 2022 2.39 Bn
Jun 30, 2022 1.53 Bn
Mar 31, 2022 1.68 Bn
Dec 31, 2021 2.13 Bn
Sep 30, 2021 2.16 Bn